Advertisement

Topics

Regeneron Hypes New Eczema Drug Dupixent In 1Q

18:06 EDT 4 May 2017 | SCRIP

Analysts have significantly upped their 2017 sales forecasts for Regeneron and Sanofi's recently launched eczema drug Dupixent on the back...

      

Related Stories

 

Original Article: Regeneron Hypes New Eczema Drug Dupixent In 1Q

NEXT ARTICLE

More From BioPortfolio on "Regeneron Hypes New Eczema Drug Dupixent In 1Q"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...

Dermatitis
Dermatitis means an inflammation of the skin. Contact dermatitis is a term used when this inflammation is caused by contact with something in the environment. The changes of dermatitis seen in the skin take the form of eczema; hence it may sometimes be r...